全文获取类型
收费全文 | 156篇 |
免费 | 9篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 4篇 |
妇产科学 | 5篇 |
基础医学 | 22篇 |
口腔科学 | 3篇 |
临床医学 | 24篇 |
内科学 | 35篇 |
皮肤病学 | 4篇 |
神经病学 | 4篇 |
特种医学 | 3篇 |
外科学 | 10篇 |
综合类 | 3篇 |
预防医学 | 3篇 |
眼科学 | 6篇 |
药学 | 18篇 |
中国医学 | 1篇 |
肿瘤学 | 19篇 |
出版年
2023年 | 2篇 |
2022年 | 9篇 |
2021年 | 19篇 |
2020年 | 6篇 |
2019年 | 8篇 |
2018年 | 8篇 |
2017年 | 9篇 |
2016年 | 5篇 |
2015年 | 7篇 |
2014年 | 18篇 |
2013年 | 14篇 |
2012年 | 17篇 |
2011年 | 11篇 |
2010年 | 3篇 |
2009年 | 1篇 |
2008年 | 4篇 |
2007年 | 8篇 |
2006年 | 6篇 |
2005年 | 1篇 |
2004年 | 2篇 |
2003年 | 6篇 |
2002年 | 1篇 |
排序方式: 共有165条查询结果,搜索用时 15 毫秒
41.
Getpook C Wattanakumtornkul S 《The journal of obstetrics and gynaecology research》2006,32(6):588-592
AIM: To assess the role of measuring endometrial thickness by transvaginal ultrasonography (TVS) as a screening tool for abnormal uterine bleeding triage in premenopausal women. METHODS: Between November 2002 and October 2004, endometrial thickness was measured by TVS in 111 premenopausal women with non-cyclic abnormal uterine bleeding before dilatation and curettage. RESULTS: Of the 111 women, 31 (27.9%) had an abnormal endometrium (hyperplasia 13.5%, polyps 5.4%, submucous myoma 5.4%, and adenocarcinoma 3.6%). An endometrial thickness of 8 mm showed optimal sensitivity and specificity (83.9% and 58.8%, respectively) and 90.4% negative predictive value (NPV) for an abnormal endometrium. When submucous myoma was excluded, the sensitivity, specificity, and NPV were 80%, 53.8%, and 89.6%, respectively. CONCLUSION: Endometrial thickness of 8 mm or less is less likely to be associated with malignant pathologies in premenopausal uterine bleeding. 相似文献
42.
43.
44.
45.
46.
Melatonin as a Topical/Systemic Formulation for the Management of Periodontitis: A Systematic Review
Thodur Madapusi Balaji Saranya Varadarajan Raghunathan Jagannathan Jaideep Mahendra Hammam Ibrahim Fageeh Hytham N. Fageeh Shazia Mushtaq Hosam Ali Baeshen Shilpa Bhandi Archana A. Gupta A. Thirumal Raj Rodolfo Reda Shankaragouda Patil Luca Testarelli 《Materials》2021,14(9)
Objectives: To qualitatively and quantitatively review the use of melatonin as a topical/systemic formulation for the management of periodontitis. Materials and methods: PubMed; Scopus; and Web of Science databases were searched using the MesH terms “melatonin” and “periodontitis”. Title and abstracts were screened to eliminate irrelevant and duplicate articles. The full text data of the screened articles were assessed using the selection criteria. Results: Of 176 identified articles (PubMed-66; Scopus-56; Web of Science-52; Cross-reference-2), only 12 studies qualified to be included in the systematic review. Four studies assessed the independent effect of 1% topical melatonin formulation while 8 articles assessed the adjunctive use of systemic melatonin formulation (1–10 mg) following scaling and root planing (SRP). All studies showed an improvement in periodontal parameters such as pocket depth, clinical attachment loss, periodontal disease index, community periodontal index, gingival bleeding scores, and prognostic marker levels in saliva and serum. A meta-analysis of data from 2 studies revealed that 1–2 mg (systemic) melatonin supplementation reduced pocket depth; although the difference was not statistically significant and hence cannot be interpreted or used for conclusive evidence. Risk of Bias Assessment tool (RoBANS) and Cochrane Collaboration RoB tool elicited a high risk of bias in the included studies. GRADE (recommendation assessment, development, and evaluation) inferred a weak recommendation for the use of melatonin in periodontitis management. Conclusions: Melatonin supplementation (topical and systemic) in periodontitis patients improved key periodontal parameters including pocket depth and clinical attachment loss. Clinical relevance: Melatonin could be a potential host modulatory agent for periodontitis management; although the data from the present review should be interpreted carefully due to the associated high risk of bias. 相似文献
47.
48.
49.
50.